Investigation Opens as FTC Sues Hims & Hers Over Data Sharing
News provided byHims & Hers Health, Inc · 2 min read
NEW YORK, Sept. 3, 2026 /CourierPR/ -- Investigations into Hims & Hers Health, Inc. ("Hims") have gained momentum following recent regulatory and financial developments. Pomerantz Law Firm, a leading corporate and securities litigation firm, is now probing claims on behalf of the company’s investors.
On July 29, 2026, the Federal Trade Commission (FTC) filed a lawsuit against Hims, accusing the company of sharing customers' medical information with third-party advertisers. The FTC's complaint alleges "deceptive and unlawful privacy practices," including the sharing of sensitive patient health details with Meta Platforms, Snap, and Facebook's parent company, reportedly through the use of its subsidiary, Hims+.
This revelation sent shockwaves through the market, causing Hims' stock to plummet $4.32 per share, or 14.73%, to close at $25.00 per share on the same day. According to Danielle Peyton, a representative from Pomerantz Law Firm, such investors are advised to stay informed and possibly seek legal counsel.
Just days later, on August 21, 2026, Bloomberg reported that Hims had been placed on notice by Visa Inc. due to excessive customer complaints in its weight-loss subscription business. Internal documents reportedly show that the company was enrolled in Visa's Acquirer Monitoring Program following a surge of customer credit card disputes in July. Each dispute will result in an $8 surcharge, totaling nearly $75,000 by September, according to the documents.
These events have added to the already growing scrutiny of Hims' billing and cancellation policies. The company's stock price subsequently dropped $2.70 per share, or 7.99%, to close at $31.08 per share on August 24, 2026.
Pomerantz Law Firm, headquartered in New York with additional offices in Chicago, Los Angeles, London, Paris, and Tel Aviv, has a distinguished history of fighting for the rights of victims of securities fraud, breaches of fiduciary duty, and corporate misconduct. Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, the firm has recovered numerous multimillion-dollar damages awards on behalf of class members.
According to Peyton, the investigations are ongoing and investors should remain vigilant. "Hims & Hers Health, Inc. faces significant challenges with both regulatory and financial oversight. Our firm is here to support any investor seeking to protect their interests," Peyton stated.
As the legal and financial landscape surrounding Hims continues to evolve, the firm's involvement underscores the importance of investor vigilance and legal representation in the face of potential misconduct.